Anti-Measles nucleoprotein抗体[2F3] (ab106292)

概述

  • 产品名称Anti-Measles nucleoprotein抗体[2F3]
    参阅全部 Measles nucleoprotein 一抗
  • 描述
    小鼠单克隆抗体[2F3] to Measles nucleoprotein
  • 经测试应用适用于: ICC/IF, ICC, WB, ELISAmore details
  • 种属反应性
    与反应: Other
  • 免疫原

    Recombinant Nucleoprotein

性能

应用

Our Abpromise guarantee covers the use of ab106292 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
ICC/IF Use at an assay dependent dilution.
ICC 1/100 - 1/500.
WB 1/200 - 1/1000. Predicted molecular weight: 58 kDa.
ELISA 1/2000 - 1/10000.

靶标

  • 相关性Involved in the encapsidating of the genome in a ratio of 1 N per 6 ribonucleotides, resulting in the protection from nucleases. The nucleocapsid (NC) has an helical structure with either 12.35 or 11.64 N per turn, approximately 20nm in diameter, with a hollow central cavity approximately 5nm in diameter. The encapsidated genomic RNA is termed the NC and serves as template for transcription and replication. During replication, encapsidation by N is coupled to RNA synthesis and all replicative products are resistant to nucleases. N is released in the blood following lysis of measles infected cells, it interacts then with human FCGR2B on immune cells, inducing apoptosis and blocking inflammatory immune response. Ntail binds to a protein on human thymic epithelial cells, termed Nucleoprotein Receptor (NR), inducing growth arrest
  • 细胞定位Virion. Host cytoplasm.
  • 别名
    • Measles nucleocapsid protein antibody
    • N antibody
    • NP antibody
    • Nucleocapsid protein antibody

Anti-Measles nucleoprotein antibody [2F3] (ab106292)参考文献

ab106292 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab106292.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"